Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Lymphoma 24Lymphoma, Non-Hodgkin 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma, Large B-Cell, Diffuse 13Leukemia, Myeloid, Acute 9Leukemia 9Neuroblastoma 8Leukemia, Lymphocytic, Chronic, B-Cell 8Hodgkin Disease 8Central Nervous System Neoplasms 8Medulloblastoma 7Rhabdoid Tumor 6Recurrence 6Multiple Myeloma 6Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, B-Cell, Marginal Zone 6Burkitt Lymphoma 6Neoplasms, Germ Cell and Embryonal 5Lymphoma, Follicular 5Lymphoma, B-Cell 5Glioma 5Brain Neoplasms 5Sarcoma 4Ovarian Neoplasms 4Oligodendroglioma 4Neoplasms 4Lung Neoplasms 4Immunoblastic Lymphadenopathy 4Astrocytoma 4

Interventions

Gemcitabine 9Carboplatin 8Paclitaxel 7Capecitabine 7Irinotecan 6pembrolizumab 3Radiotherapy 3Oxaliplatin 3Fluorouracil 3Filgrastim 3Cisplatin 3Bevacizumab 3etoposide phosphate 2Surveys and Questionnaires 2Peripheral Blood Stem Cell Transplantation 2Magnetic Resonance Spectroscopy 2Leucovorin 2Genetic Testing 2FAPI-46 2Etoposide 2Erlotinib Hydrochloride 2Docetaxel 2Cyclophosphamide 2Amifostine 2Albumin-Bound Paclitaxel 2tislelizumab 1tegafur-gimeracil-oteracil 1spartalizumab 1sintilimab 1erythromycin propionate-N-acetylcysteinate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Neoplasms, Unknown Primary × etoposide phosphate × Clear all
NCT00003657 2017-01-20

High-dose ICE With Amifostine

Dana-Farber Cancer Institute

Phase 2 Completed
24 enrolled
CNSGenitourinaryGynecologicHead & NeckSarcomaThoracic

AIDS-related Kaposi sarcoma, Testicular Germ Cell Tumor, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Unknown Primary, Ovarian Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

NCT00193596 2013-05-03

Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site

SCRI Development Innovations, LLC

Phase 3 Completed
198 enrolled 7 charts
Tumor-Agnostic

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡